Participated · Seed · Jun 2019

Aromyx applies biotechnology and data science to capture and digitize sensory information from human olfactory and taste receptors, creating quantitative representations of smell and taste. The company has built a proprietary platform and the largest database of human receptors, ingredients/chemicals and word descriptors to test products and ingredients against these receptors. Its products and services are used by multiple Fortune 500 companies across food & beverage, CPG, pharmaceuticals and chemicals. Aromyx provides direct testing services, data analysis, and software tools to help customers design products, target demographics, forecast trends and improve sustainability and health outcomes. The company tested over 100 products in 2020 and was on track to more than triple that number in 2021 as capacity ramps up. Planned uses of the Series A proceeds include increasing capacity and automation, generating more data, improving AI algorithms, and expanding lab and software teams to meet growing demand. Aromyx applies biotechnology and data science to capture sensory data, using biological receptors from the human nose to create digital representations of smell. Its EssenceChip™ is a biosensor that scientifically records flavors and fragrances with reproducible results for real-world environments. The company's Allegory Database™ provides a basis for machine learning analysis of flavors and fragrances. Aromyx's products and services are in use at several Fortune 500 companies across pharmaceuticals, chemicals, food & beverage and consumer packaged goods. The company is led by newly appointed CEO Dr. Josh Silverman and founder/chairman Chris Hanson. Aromyx closed a $3M seed financing round and intends to use the funds to grow the scientific team and continue executing technology development projects. Aromyx develops technologies to enable scientific, reproducible measurement and digitization of taste and scent, centered on its EssenceChip disposable biosensor. The EssenceChip places human taste and olfactory receptors into a biochip for measurement and digitization. The platform is targeted at food and beverage, flavor and fragrance, consumer packaged goods, chemical and agricultural industries. The company was founded by Chris Hanson and was incubated at Stanford’s StartX accelerator and the Plug and Play Ventures Materials program. Aromyx is raising $3.6M in growth capital on Propel(x)’s platform. It is currently in advanced negotiations with some of the largest consumer packaged goods companies.